<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on DRF from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated DRF news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 23:53:23 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=DRF" rel="self" type="application/rss+xml" />

	
<item><title>Dabur to re-expand its pharma research</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3922211&amp;HITNO=0&amp;MSIZE=3&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=DRF&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3922211&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2475756743%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3922211&amp;HITNO=0&amp;MSIZE=3&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=DRF&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3922211&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2475756743%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Standard India:</description></item>
<item><title>Dr. Reddy's And Rheoscience Announce Headline Results From First Phase III Clinical Trial of Balaglitazone (DRF 2593)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3861340&amp;HITNO=1&amp;MSIZE=3&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=DRF&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3861340&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444409121%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3861340&amp;HITNO=1&amp;MSIZE=3&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=DRF&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3861340&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2444409121%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmaceutical Online:</description></item>
<item><title>Dr. Reddy's and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3852759&amp;HITNO=2&amp;MSIZE=3&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=DRF&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3852759&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2440775154%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3852759&amp;HITNO=2&amp;MSIZE=3&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=DRF&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3852759&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2440775154%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
</channel></rss>